ORSANCO reported 0.434 ng/L cocaine in an effluent-influenced Ohio River sample near Louisville, while a Kentucky study detected xylazine in 61.6% of 688 daily wastewater samples from roadway sites and treatment plants. Neither result means those same concentrations were present in Louisville drinking water.
- Cocaine at sample 17: below reporting limit
- Cocaine at effluent-influenced sample 18: 0.434 ng/L
- Kentucky xylazine study: 424 of 688 wastewater samples positive
- Wastewater treatment-plant subset: 25.8% positivity in 66 samples
The words “cocaine in the Ohio River” and “xylazine found in Kentucky wastewater” sound like one story about contaminated drinking water. They are not. Both detections are real, but they came from different studies, different years, different sample types, and different public-health purposes. Treating wastewater, river water, finished drinking water, and household tap water as the same thing would turn accurate research into misinformation.
ORSANCO’s 2009 Ohio River screening reported cocaine below the method reporting limit at a mainstem location near Louisville and 0.434 nanograms per liter at a nearby effluent-influenced location. A 2024 peer-reviewed University of Kentucky study looked for xylazine in wastewater collected from roadway sites and wastewater treatment plants across Kentucky. It detected xylazine in 61.6% of 688 daily wastewater samples. Neither study measured xylazine or cocaine at Louisville kitchen taps.
What the Ohio River study found near Louisville
ORSANCO sample 17 came from the Ohio River mainstem at river mile 600.5. Cocaine was below the method reporting limit there. Sample 18 came from river mile 612.2 and was labeled effluent influenced. Cocaine was reported at 0.434 ng/L in that sample. Benzoylecgonine, a primary cocaine metabolite commonly used as an indicator of consumption, measured 2.05 ng/L in sample 17 and 4.46 ng/L in sample 18.
These are trace environmental concentrations. A detection confirms that the analytical method found the compound above its reporting threshold. It does not tell us that the same concentration survived drinking-water treatment, entered the distribution system, or reached a specific home. It also does not establish a health effect at that concentration.
The effluent-influenced label is critical. Researchers often sample near discharges because those locations help identify pathways and “worst reasonable” environmental signals. That makes the data valuable for source tracking, but it makes the sample less suitable as a stand-in for the entire river.
What the Kentucky xylazine study measured
Xylazine is a veterinary sedative that has increasingly appeared in the illicit drug supply, often with fentanyl. The University of Kentucky-led study compared wastewater detection with forensic and overdose surveillance from 2019 through 2023. Researchers collected wastewater from five rest areas, two truck weigh stations, and four wastewater treatment plants.
The study detected xylazine in 424 of 688 daily samples, a positivity rate of 61.6%. Roadway-site positivity increased over the study period. The wastewater-treatment-plant subset had an overall detection rate of 25.8% across 66 samples collected in 2022. The authors concluded that wastewater signals suggested broad geographic exposure and could support public-health surveillance.
The result is about population drug-use patterns. Wastewater surveillance works because people excrete drugs or metabolites into sewer systems. Researchers can analyze the pooled signal without identifying individuals. Similar approaches are used for infectious diseases and other community trends.
Why wastewater surveillance is not a tap-water test
Wastewater is what homes, businesses, and institutions send away after use. Source water is what a drinking-water utility draws from a river, reservoir, aquifer, or well. Finished water is what leaves the drinking-water plant after treatment. Distribution water travels through mains. Tap water comes through a building’s service line and plumbing.
Each stage has different contaminants, concentrations, treatment barriers, and sampling objectives. A positive wastewater sample does not mean the same compound is present in the source water at the same level. A source-water detection does not mean treatment failed. A finished-water result does not automatically describe every household fixture.
The direction of flow matters too. Wastewater treatment plants discharge to receiving waters, but drinking-water intakes, river travel time, dilution, degradation, adsorption, and downstream treatment all affect what happens next. To make a tap-water claim, researchers need an actual finished-water or tap-water sample analyzed with an appropriate method.
What the studies can legitimately tell homeowners
First, human-used chemicals leave measurable fingerprints in the water cycle. That fact should strengthen support for source control, wastewater research, and responsible disposal. Second, advanced laboratory methods can detect compounds at extremely low concentrations. “Detected” is not a synonym for “dangerous at the detected level.”
Third, illegal-drug markers can be useful public-health data. A community may see a wastewater signal before traditional overdose or seizure data provide a complete picture. That can inform harm-reduction outreach and surveillance. It is not a reason to stigmatize a neighborhood or claim that its drinking water contains drugs.
Fourth, the ORSANCO study was collected in 2009. It documents occurrence at that time and location. The UK xylazine study covered 2019–2023 and different sites. Neither should be presented as a current Louisville tap-water measurement in 2026.
The health-risk question requires more than a detection
Risk depends on concentration, duration, route, frequency, toxicity, and the population exposed. A therapeutic or illicit dose is not comparable to a trace environmental result without calculation and context. Wastewater may contain high biological and chemical loads before treatment and is not intended for drinking.
ORSANCO described its work as a preliminary screening study and cautioned that environmental detections did not by themselves establish a causal human-health risk. The UK xylazine project focused on surveillance of drug exposure trends, not drinking-water safety. Those study purposes should remain attached to the findings.
If a headline omits the words “wastewater,” “river sample,” “effluent influenced,” or “below the reporting limit,” it may be technically based on a study while still giving the reader the wrong conclusion.
What a homeowner should do with this information
Do not order an expensive “illegal drug water panel” because of a statewide wastewater study unless there is a specific reason and a qualified laboratory can explain what the result would mean. Start with the current Louisville Water report and any targeted emerging-contaminant information. For private wells, prioritize risks tied to local land use, septic systems, flooding, bacteria, nitrate, and known nearby sources.
If a treatment seller claims a system removes cocaine, xylazine, or “all pharmaceuticals,” ask for the exact product listing and test protocol. NSF/ANSI 401 covers selected emerging compounds on listed products; it is not a blanket certification for every drug. Reverse osmosis and activated carbon may reduce many organic compounds, but performance must be supported for the complete model and maintained over its rated life.
The most direct community action is upstream: support proper medication and hazardous-waste disposal, effective wastewater treatment, industrial discharge controls, and honest public reporting. For household treatment, focus on the contaminants supported by current source data or a properly collected sample.
The gain: use frightening data correctly
The absolute truth is enough. Trace cocaine was reported in one effluent-influenced Ohio River sample near Louisville. Xylazine appeared frequently in Kentucky wastewater surveillance. Those facts show that human behavior leaves chemical signals in the water cycle.
They do not show that Louisville tap water contained those drugs at the reported levels. Keeping that boundary clear is not minimizing the problem—it is what makes the information actionable. When sample type, concentration, date, and purpose are stated plainly, homeowners can direct concern toward monitoring, source control, and verified treatment instead of buying fear.
This article uses source-specific language. River, wastewater, raw-water, finished-water, and tap-water results are not treated as interchangeable. Detection does not automatically establish a health effect, and a regulatory change does not erase toxicology. Information is educational and not medical advice.
Primary sources and further reading
- ORSANCO: Screening Study of Emerging Contaminants in the Ohio River Basin
- ORSANCO study PDF
- University of Kentucky: Wastewater Surveillance for Xylazine in Kentucky
- AJPM Focus study DOI
Frequently asked questions
Does a positive wastewater sample mean the drug is in my tap water?
No. Wastewater is collected to understand what a population discharges after use. Drinking-water source, treatment, distribution, and tap sampling are separate stages that require separate data.
Why measure drugs in wastewater?
Wastewater surveillance can reveal community-level trends faster than some traditional reporting systems. It is primarily a public-health surveillance tool, not a drinking-water compliance test.
Why discuss these findings on a water-treatment site?
Because sensational headlines can collapse wastewater, river water, finished water, and tap water into one category. Homeowners make better decisions when the sample type and purpose are explicit.
